awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33437691-F76EC988-F61D-4C1F-96BB-C3019B387847
Q33437691-F76EC988-F61D-4C1F-96BB-C3019B387847
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33437691-F76EC988-F61D-4C1F-96BB-C3019B387847
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.
P2860
Q33437691-F76EC988-F61D-4C1F-96BB-C3019B387847
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33437691-F76EC988-F61D-4C1F-96BB-C3019B387847
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6b271bc45ee27b3535ed73c1be9cb7ad1a7c7628
P2860
A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma